Inventor · disambiguated record
Kang Dai
Also filed as: DAI KANG
7 granted patents·9 pending applications·92 citations·filing 2001–2016
83Inventor score
Top patents by PatentIndex Score
16 records- 0192US8623885B2Fused tricyclic dual inhibitors of CDK 4/6 and FLT3CHEN XIAOQI·Filed 2012·Granted Jan 7, 2014·44 cites·35 claims
- 0290US7045527B2Piperidine derivativesAMGEN INC·Filed 2003·Granted May 16, 2006·39 cites·25 claims
- 0380US7572783B2Substituted benzofused heterocyclesAMGEN INC·Filed 2005·Granted Aug 11, 2009·3 cites·20 claims
- 0475US8389533B2Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitorsCONNORS RICHARD V·Filed 2009·Granted Mar 5, 2013·3 cites·20 claims
- 0563US9359355B2Fused tricyclic dual inhibitors of CDK 4/6 and FLT3AMGEN INC·Filed 2013·Granted Jun 7, 2016·0 cites·14 claims
- 0663US6858619B2Fused heterocyclic compoundsAMGEN INC·Filed 2002·Granted Feb 22, 2005·3 cites·47 claims
- 0762US2009226436A1Novel receptorsAMGEN SF LLC·Filed 2009·Application pending·0 cites
- 0862US2008113449A1Novel receptorsTIAN HUI·Filed 2008·Application pending·0 cites
- 0957US2007141644A1Novel ReceptorsTIAN HUI·Filed 2007·Application pending·0 cites
- 1056US2003082585A1Novel receptorsTULARIK·Filed 2002·Application pending·0 cites
- 1154US8980903B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsAMGEN INC·Filed 2014·Granted Mar 17, 2015·0 cites·22 claims
- 1254US2016368933A1Fused tricyclic dual inhibitors of cdk 4/6 and flt3AMGEN INC·Filed 2016·Application pending·0 cites
- 1350US2003027252A1Novel receptorsTULARIK INC·Filed 2001·Application pending·0 cites
- 1450US2007078152A1Piperidine derivativesAMGEN INC·Filed 2005·Application pending·0 cites
- 1547US2005170397A1Novel receptorsTULARIK INC·Filed 2005·Application pending·0 cites
- 1646US2007135425A1Fused heterocyclic compoundsAMGEN INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kang Dai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →